SEACROSS PHARMA USA INC

Overview

SEACROSS PHARMA USA INC is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering BORTEZOMIB; CALCIUM LEVOFOLINATE; THIOTEPA.

API / Drug Master Files

SEACROSS PHARMA USA INC holds 3 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• BORTEZOMIBActive2024-01-09
• THIOTEPAActive2023-08-15
• CALCIUM LEVOFOLINATEActive2023-05-31
• ETOPOSIDEInactive2023-09-01
• METHOTREXATEInactive2023-04-23
• CARFILZOMIBInactive2023-04-03

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SEACROSS PHARMA USA INC in our records. PharmaTek screens the full directory against live FDA enforcement data.